Pei‐Zhen Tao
- Biochemistry top 10%
- Pharmacology top 10%
-
- HIV/AIDS drug development and treatment 6
-
- Herpesvirus Infections and Treatments 4
- Hepatitis B Virus Studies 3
-
- Heat shock proteins research 4
- Chemical Synthesis and Analysis 3
- Biochemical and Molecular Research 3
-
- Toxin Mechanisms and Immunotoxins 3
-
- HIV Research and Treatment 2
- Journals
- Journal of Virology (1 paper)The Journal of Infectious Diseases (1 paper)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Pei‐Zhen Tao
21 papers receiving 553 citations
Peers
Comparison fields: 5 of 79
- Biochemistry 75
- Pharmacology 51
- Infectious Diseases 89
- Complementary and alternative medicine 37
- Toxicology 14
Countries citing papers authored by Pei‐Zhen Tao
This map shows the geographic impact of Pei‐Zhen Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Zhen Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Zhen Tao more than expected).
Fields of papers citing papers by Pei‐Zhen Tao
This network shows the impact of papers produced by Pei‐Zhen Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Zhen Tao. The network helps show where Pei‐Zhen Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pei‐Zhen Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 13 | |
| 2 | 2012 | 11 | |
| 3 | 2011 | 10 | |
| 4 | 2011 | 3 | |
| 5 | [Synthesis and antiviral activities of geldanamycin analog TC-GM in vitro]. | 2011 | 1 |
| 6 | [Anti-HIV-1 activity and structure-activity relationship of pyranocoumarin analogs]. | 2011 | 1 |
| 7 | [Antiviral activities of cycloheximide and its derivatives]. | 2010 | 2 |
| 8 | 2009 | 10 | |
| 9 | 2009 | 332 | |
| 10 | 2009 | 1 | |
| 11 | Improved synthesis and pharmacological evaluation of racemic 11 -demethylcalanolide A. | 2008 | 1 |
| 12 | 2004 | 65 | |
| 13 | [Inhibition of duck hepatitis B virus DNA replication by antisense phosphorothioate oligodeoxynucleotides in vitro and in vivo]. | 2003 | 2 |
| 14 | 2000 | 15 | |
| 15 | [Synthesis of optically active (R)- and (S)-tai-ding-an(TDA) and their anti-HSV activity evaluation]. | 1996 | 1 |
| 16 | 1994 | 3 | |
| 17 | 1989 | 5 | |
| 18 | 1988 | 9 | |
| 19 | 1985 | 44 | |
| 20 | 1984 | 12 |
About Pei‐Zhen Tao
Pei‐Zhen Tao is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 21 papers that have together received 582 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), Herpesvirus Infections and Treatments (4 papers), Heat shock proteins research (4 papers), Chemical Synthesis and Analysis (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Biochemical and Molecular Research (3 papers), Hepatitis B Virus Studies (3 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Biochemistry (75 citations), Pharmacology (51 citations) and Infectious Diseases (89 citations). Pei‐Zhen Tao has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Zhuang Li, Weimin Zhao, Yuhuan Li, Jianping Zuo, Houfu Liu, Rujun Zhang, Chuan Li, Guifeng Wang, Yudan Ren and Qun‐Fang Liu. Their work appears in journals such as Journal of Virology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.